热门资讯> 正文
Scilex Says New US Patent to Be Issued for Pain Treatment
2024-08-21 21:49
09:49 AM EDT, 08/21/2024 (MT Newswires) -- Scilex Holding (SCLX) said Wednesday that it is set to receive a new patent from the US Patent and Trademark Office later this year covering its claims related to acute pain treatment.
The company said the US Patent and Trademark Office "has allowed numerous claims" from its patent application, but did not disclose further details.
Scilex said the new patent is expected to strengthen its intellectual property position and coverage for Elyxyb, its acute migraine treatment.
Price: 1.29, Change: +0.03, Percent Change: +2.30
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
